Cargando…
Efficacy of Dendritic Cells Matured Early with OK-432 (Picibanil®), Prostaglandin E(2), and Interferon-α as a Vaccine for a Hormone Refractory Prostate Cancer Cell Line
Dendritic cells (DCs) are potent antigen-presenting cells. OK432 (Picibanil®) was introduced as a potent stimulator of DC maturation in combination with prostaglandin-E(2) and interferon-α. We compared the efficacy of a DC-prostate cancer vaccine using early-mature DCs stimulated with OK432, PGE2 an...
Autores principales: | Yoo, Changhee, Do, Hyun-Ah, Jeong, In Gab, Park, Hongzoo, Hwang, Jung-Jin, Hong, Jun Hyuk, Cho, Jin Seon, Choo, Myong-Soo, Ahn, Hanjong, Kim, Choung-Soo |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2923792/ https://www.ncbi.nlm.nih.gov/pubmed/20808670 http://dx.doi.org/10.3346/jkms.2010.25.9.1284 |
Ejemplares similares
-
Picibanil (OK-432) in the treatment of head and neck lymphangiomas in children
por: Rebuffini, Elena, et al.
Publicado: (2012) -
Treatment of lymphangiomas by means of sclerotherapy with OK-432 (Picibanil®) is safe and effective – A retrospective case series
por: Fasching, G., et al.
Publicado: (2022) -
Successful pleurodesis with OK-432 in preterm infants with persistent pleural effusion
por: Kim, Jeong Eun, et al.
Publicado: (2012) -
Interferon-α-inducible Dendritic Cells Matured with OK-432 Exhibit TRAIL and Fas Ligand Pathway-mediated Killer Activity
por: Koya, Terutsugu, et al.
Publicado: (2017) -
Percutaneous Treatment of Renal Cysts with OK-432 Sclerosis
por: Choi, Young Deuk, et al.
Publicado: (2007)